According to Teva Pharmaceutical Industries's latest financial reports the company's current revenue (TTM ) is $16.61 Billion USD. In 2024 the company made a revenue of $16.54 Billion USD an increase over the revenue in the year 2023 that were of $15.84 Billion USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2025 (TTM) | $16.61 B | 0.44% |
2024 | $16.54 B | 4.4% |
2023 | $15.84 B | 6.18% |
2022 | $14.92 B | -6.01% |
2021 | $15.87 B | -4.68% |
2020 | $16.65 B | 1.52% |
2019 | $16.40 B | -12.97% |
2018 | $18.85 B | -16% |
2017 | $22.44 B | 2.48% |
2016 | $21.90 B | 11.45% |
2015 | $19.65 B | -3.06% |
2014 | $20.27 B | -0.21% |
2013 | $20.31 B | -0.01% |
2012 | $20.31 B | 10.95% |
2011 | $18.31 B | 13.59% |
2010 | $16.12 B | 15.99% |
2009 | $13.89 B | 25.39% |
2008 | $11.08 B | 17.83% |
2007 | $9.40 B | 11.89% |
2006 | $8.40 B | 60.15% |
2005 | $5.25 B | 9.41% |
2004 | $4.79 B | 46.47% |
2003 | $3.27 B | 30.09% |
2002 | $2.51 B | 21.24% |
2001 | $2.07 B | 18.71% |
2000 | $1.74 B | 36.45% |
1999 | $1.28 B | 14.92% |
1998 | $1.11 B | -0.09% |
1997 | $1.11 B | 17.1% |
1996 | $0.95 B |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
![]() Novartis NVS | $53.22 B | 220.33% | ๐จ๐ญ Switzerland |
![]() Sanofi SNY | $47.43 B | 185.48% | ๐ซ๐ท France |
![]() GlaxoSmithKline GSK | $40.60 B | 144.41% | ๐ฌ๐ง UK |
![]() Pfizer PFE | $62.46 B | 275.94% | ๐บ๐ธ USA |
![]() Merck MRK | $63.92 B | 284.72% | ๐บ๐ธ USA |
![]() Dr. Reddy's Laboratories RDY | $3.70 B | -77.72% | ๐ฎ๐ณ India |
![]() AstraZeneca AZN | $54.98 B | 230.92% | ๐ฌ๐ง UK |